C3 and metabolic syndrome: In proportion to the number of AT, anaphylatoxins like C3a and C5a trigger responses in the cyto/chemokine pathway, thus inducing inflammation and mediating metabolism associated with insulin resistance, diabetes, metabolic syndrome (MetS), and cardiovascular risk factors [44].